EFFICACY OF RASNADI BASTI AND VARDHAMANA SHATAPUSHPA KALPA ORALLY IN THE MANAGEMENT OF VANDHYATVA(FEMALE INFERTILITY)
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2020/11/029292
- Lead Sponsor
- IPGT and RA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients having active married life minimum 1 year and suffering from Infertility with
atleast2 or more consecutive anovulatory cycles.
2. Primary and secondary both types of infertile patients having anovulatory cycle or
with immature ovarian follicle.
3. Patient eligible for Basti.
4. Patient willing for Basti.
5. Patients willing to participate in trial
1. Female Patients having age less than 20years and more than 40years.
2. Congenital deformities and infectious diseases of reproductive tract like tuberculosis,
Sexually transmitted diseases and carcinoma
3. Chronic systemic diseases like Uncontrolled Diabetes &Hypertension, HIV, TB, etc.
4. Patient not eligible for Basti.
5. Patient not willing for Basti
6. Pitta prakriti females.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that the trial drugs will induce the ovulation. <br/ ><br>Timepoint: After the follow up period <br/ ><br>
- Secondary Outcome Measures
Name Time Method Trail drugs will improve menstrual abnormalities associated with <br/ ><br>anovulation like irregular, scanty menstruation, dysmenorrhoea.Timepoint: After the follow up period